GOLDMAN SACHS GROUP INC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 76 filers reported holding HUMACYTE INC in Q2 2023. The put-call ratio across all filers is 45.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of HUMACYTE INC
ValueSharesWeighting
Q2 2024$3,655,560
+1089.1%
761,575
+670.4%
0.00%
Q1 2024$307,430
+7.5%
98,852
-1.8%
0.00%
Q4 2023$286,005
-26.3%
100,706
-24.0%
0.00%
Q3 2023$388,313
+82.1%
132,530
+77.8%
0.00%
Q2 2023$213,210
+9.7%
74,549
+18.6%
0.00%
Q1 2023$194,309
+65.6%
62,883
+13.1%
0.00%
Q4 2022$117,303
+50029.5%
55,594
-22.5%
0.00%
Q3 2022$234
+69.6%
71,758
+67.3%
0.00%
Q2 2022$138
-100.0%
42,903
-55.3%
0.00%
Q1 2022$678,000
+20.4%
95,966
+23.5%
0.00%
Q4 2021$563,00077,6850.00%
Other shareholders
HUMACYTE INC shareholders Q2 2023
NameSharesValueWeighting ↓
Endowment Wealth Management, Inc. 100,518$482,4860.35%
Monashee Investment Management LLC 280,000$1,344,0000.17%
United Asset Strategies, Inc. 218,308$1,047,8780.10%
HAMILTON LANE ADVISORS LLC 21,893$105,0860.08%
GSA CAPITAL PARTNERS LLP 224,179$1,0760.08%
David J Yvars Group 22,750$109,2000.07%
ARS Investment Partners, LLC 116,419$558,8110.05%
EntryPoint Capital, LLC 5,180$24,8640.04%
Virtu Financial LLC 103,163$4950.04%
Anson Funds Management LP 50,000$240,0000.03%
View complete list of HUMACYTE INC shareholders